Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOCAL open-label extension of voclosporin in adolescents with lupus nephritis
MOH_2023-12-18_013029Phase 3Not yet recruiting
- Sponsor
- Aurinia
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of voclosporin in lupus nephritis (LN), sponsored by Aurinia. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on MOH_2023-12-18_013029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-12-18_013029.